[ad_1]
OXFORD, England – (BUSINESS WIRE) – Perspectum Diagnostics announced the awarding of the Innovate UK grant
develop a technology that will improve diagnosis and monitoring
type 2 diabetes (T2D).
The Innovate UK grant will allow Perspectum to stratify patients with T2DM using
quantitative MRI evaluation of badociated organs, including liver,
kidneys, pancreas, spleen and aorta. The combination of these biomarkers in a
medical device will support clinical management based on one,
Profitable MRI. S & P based on the existing internal system of Perspectum
this project will provide stratification of the disease, improve
patient compliance, reduce the costs of the NHS and allow
precision processing. This multi-organ project was preceded
through Perspectum's MRI-based research using the British biobank, which
have highlighted the considerable burden of unrecognized liver diseases, such as
like NAFLD, which is three times more prevalent in T2D.
Dr. Gaya Thanablasingham, Endocrinology and Metabolism Specialist
Medicine at the NHS Foundation of Oxford University Hospitals, believes
that "this project has the potential to significantly improve our
understanding of organic dysfunction and the severity of T2D. Hope this
we will improve the stratification of patients, which will accelerate
diagnosis of diabetes-related complications and support development
personalized treatments. "
Consultant in Endocrinology, Diabetes and General Medicine at the Royal
Sarah Ali of the London NHS Foundation Trust added, "T2D is dramatically
worldwide and can cause damage to multiple organs over time if
not treated effectively. This innovative research study will allow us to
visualize these organs from the beginning of DT2, which will facilitate
stratify treatment in the management of the disease. "
Diabetes is a global pandemic with increasing prevalence.
Affecting several organs, it can not currently be treated.
thanks to complex clinical management – and the diagnosis is difficult. AT
currently, care of diabetic patients is based on routine biochemical badyzes.
tests that independently control glycemic control, cardiovascular risk,
chronic kidney disease and liver health. In order
For the treatment to be effective, the diagnosis must explain the presence
or absence of multi-organ complications.
Professor Dan Cuthbertson (University of Liverpool), consultant
Diabetologist at Aintree University Hospital, who heads the
Liverpool component of the research project, commented on the results of Perspectum
reward: "Screening for liver and cardiovascular complications is still
sub-optimal and this multi-organ evaluation in diagnosis and treatment
DT2 allows us to better understand the prevalence and progression of
disease and the impact of different treatments. J & # 39; hope
lead to better stratification of the treatment ".
Source link
